Welcome
Testing with Compliance and Confidence
Products and consultancy to meet clinical and ISO 15189 regulatory needs for rare disorders and in-house procedures.
Innovative Solutions for Tomorrow's Challenges
ADAMTS13 assays
Set up testing for ADAMTS13 activity, antigen, open/close, IgG antibody and functional antibody assays for both clinical and research use.
Assays will be set up for direct user applications, accurately monitor patients on any Standard Of Care (SOC) or research therapeutics.
ISO-Check products
INNOVATIVE PRODUCTS & SOLUTIONS FOR RARE DISORDERS.
Provide assurances with our confirmatory ISO-Check product range to support diagnosis and monitoring of TTP.
- Diagnostic controls for TTP diagnosis, method specific (FRET 10% or CLIA 3%).
- Controls levels for caplacizumab cessation decision points (levels of ADAMTS13 antigen and activity levels of 25 -30%).
- Capture ADAMTS13 antigen and antibody ELISA plates.
- ADAMTS13 IgG cub spacer antibodies controls to monitor Rituximab efficacy.
ISO15189 Accreditation solutions
We provides consultancy and tailored solutions to ensure your laboratory meets the necessary standards and regulations to help fulfil the requirements of ISO 15198,2022.
Enlist a specialist to take the hassle of the ISO 15189 accreditation process of any equipment or processes you require!
Training and Development
Haemostasis Training for FRCPath exams, Quality assurances, Assay development, Assay limitations, Diagnosis pathways and and much more tailored for the individual or the organization.
Antiplatelet drug responses & platelet activation evaluation
The inability to prevent ischemic stroke or major vascular events despite optimal use of anti-platelet medications is multi-factorial hence we evaluate using a multiple marker model for a tailor made assessment for the individual.
Request a new product
Require ADAMTS13 recombinant made or Antibodies eluted?
Require samples for research or validations?